Lumexa Imaging Holdings, Inc. Common Stock (LMRI) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Services · United States · ISIN US5502491062

Price
11.73 USD
Market cap
1.13 bn USD
P/E (2025)
–
P/S (2025)
1.10
Dividend yield
0.00 %
Net margin
-4.60 %
Return on equity (ROE)
-8.04 %
Return on assets (ROA)
-2.67 %

Lumexa Imaging Holdings, Inc. Common Stock financials

Fiscal year20242025
Revenue948.87 m USD1.02 bn USD
Gross profit96.26 m USD117.19 m USD
Operating income55.24 m USD26.73 m USD
EBIT56.83 m USD86.32 m USD
Net income-94.10 m USD-47.10 m USD
Diluted EPS – continuing operations-1.00 USD-0.66 USD

Full history since 2023, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Lumexa Imaging Holdings, Inc. Common Stock

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.